English
简体中文
Total: £ 56.28
Published Date: 2025-11-10 | Pages: 138 | Tables: 131 | Medical Care
The global Biologics Outsourcing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Biologics outsourcing services refer to the practice of pharmaceutical and biotechnology companies partnering with external organizations to handle various aspects of the development and manufacturing of biologic drugs. Biologics are complex therapeutic molecules produced using living organisms or their components, such as proteins, antibodies, or nucleic acids.
Outsourcing these services allows companies to leverage the expertise, infrastructure, and resources of specialized contract service providers, often referred to as Contract Development and Manufacturing Organizations (CDMOs) or Contract Research Organizations (CROs).
The global demand for biologic drugs continued to rise, driven by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in biotechnology. This heightened demand led to greater outsourcing of biologics development and manufacturing to specialized service providers.
The development and approval of biosimilar drugs, which are highly similar versions of approved biologic drugs, gained momentum. As biosimilars offer cost-effective alternatives to branded biologics, there was a growing need for outsourcing services to support biosimilar development, including analytical testing, process development, and manufacturing.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biologics Outsourcing Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
Segment by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other
Segment by Application
SMBs
Large Companies
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Biologics Outsourcing Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Biologics Outsourcing Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biologics Outsourcing Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cell and Gene Therapies
1.2.3 Antibodies
1.2.4 Vaccines
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Biologics Outsourcing Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologics Outsourcing Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Biologics Outsourcing Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Biologics Outsourcing Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Biologics Outsourcing Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cell and Gene Therapies Market Size by Players
3.3.2 Antibodies Market Size by Players
3.3.3 Vaccines Market Size by Players
3.3.4 Other Market Size by Players
3.4 Global Biologics Outsourcing Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biologics Outsourcing Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biologics Outsourcing Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Biologics Outsourcing Services Market Size by Type (2020-2031)
6.4 North America Biologics Outsourcing Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biologics Outsourcing Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Biologics Outsourcing Services Market Size by Type (2020-2031)
7.4 Europe Biologics Outsourcing Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biologics Outsourcing Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Biologics Outsourcing Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Biologics Outsourcing Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Biologics Outsourcing Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Biologics Outsourcing Services Market Size by Type (2020-2031)
9.4 Central and South America Biologics Outsourcing Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biologics Outsourcing Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Biologics Outsourcing Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Biologics Outsourcing Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biologics Outsourcing Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics Outsourcing Services Product Features and Attributes
11.1.4 Lonza Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.1.5 Lonza Biologics Outsourcing Services Revenue by Product in 2024
11.1.6 Lonza Biologics Outsourcing Services Revenue by Application in 2024
11.1.7 Lonza Biologics Outsourcing Services Revenue by Geographic Area in 2024
11.1.8 Lonza Biologics Outsourcing Services SWOT Analysis
11.1.9 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Corporation Information
11.2.2 Catalent Business Overview
11.2.3 Catalent Biologics Outsourcing Services Product Features and Attributes
11.2.4 Catalent Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.2.5 Catalent Biologics Outsourcing Services Revenue by Product in 2024
11.2.6 Catalent Biologics Outsourcing Services Revenue by Application in 2024
11.2.7 Catalent Biologics Outsourcing Services Revenue by Geographic Area in 2024
11.2.8 Catalent Biologics Outsourcing Services SWOT Analysis
11.2.9 Catalent Recent Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Corporation Information
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics Biologics Outsourcing Services Product Features and Attributes
11.3.4 Samsung Biologics Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.3.5 Samsung Biologics Biologics Outsourcing Services Revenue by Product in 2024
11.3.6 Samsung Biologics Biologics Outsourcing Services Revenue by Application in 2024
11.3.7 Samsung Biologics Biologics Outsourcing Services Revenue by Geographic Area in 2024
11.3.8 Samsung Biologics Biologics Outsourcing Services SWOT Analysis
11.3.9 Samsung Biologics Recent Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Corporation Information
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services Product Features and Attributes
11.4.4 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services Revenue by Product in 2024
11.4.6 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services Revenue by Application in 2024
11.4.7 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services Revenue by Geographic Area in 2024
11.4.8 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services SWOT Analysis
11.4.9 FUJIFILM Diosynth Biotechnologies Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biologics Outsourcing Services Product Features and Attributes
11.5.4 Boehringer Ingelheim Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.5.5 Boehringer Ingelheim Biologics Outsourcing Services Revenue by Product in 2024
11.5.6 Boehringer Ingelheim Biologics Outsourcing Services Revenue by Application in 2024
11.5.7 Boehringer Ingelheim Biologics Outsourcing Services Revenue by Geographic Area in 2024
11.5.8 Boehringer Ingelheim Biologics Outsourcing Services SWOT Analysis
11.5.9 Boehringer Ingelheim Recent Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Corporation Information
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Biologics Outsourcing Services Product Features and Attributes
11.6.4 WuXi AppTech Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.6.5 WuXi AppTech Recent Developments
11.7 Recipharm
11.7.1 Recipharm Corporation Information
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Biologics Outsourcing Services Product Features and Attributes
11.7.4 Recipharm Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.7.5 Recipharm Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Corporation Information
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Biologics Outsourcing Services Product Features and Attributes
11.8.4 Thermo Fisher Scientific Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Corporation Information
11.9.2 AGC Biologics Business Overview
11.9.3 AGC Biologics Biologics Outsourcing Services Product Features and Attributes
11.9.4 AGC Biologics Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.9.5 AGC Biologics Recent Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Corporation Information
11.10.2 Rentschler Biopharma Business Overview
11.10.3 Rentschler Biopharma Biologics Outsourcing Services Product Features and Attributes
11.10.4 Rentschler Biopharma Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Corporation Information
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biologics Outsourcing Services Product Features and Attributes
11.11.4 KBI Biopharma Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.11.5 KBI Biopharma Recent Developments
11.12 Siegfried
11.12.1 Siegfried Corporation Information
11.12.2 Siegfried Business Overview
11.12.3 Siegfried Biologics Outsourcing Services Product Features and Attributes
11.12.4 Siegfried Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.12.5 Siegfried Recent Developments
11.13 Aenova Group
11.13.1 Aenova Group Corporation Information
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Biologics Outsourcing Services Product Features and Attributes
11.13.4 Aenova Group Biologics Outsourcing Services Revenue and Gross Margin (2020-2025)
11.13.5 Aenova Group Recent Developments
12 Biologics Outsourcing ServicesIndustry Chain Analysis
12.1 Biologics Outsourcing Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biologics Outsourcing Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biologics Outsourcing Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Biologics Outsourcing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biologics Outsourcing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biologics Outsourcing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biologics Outsourcing Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biologics Outsourcing Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Biologics Outsourcing Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Biologics Outsourcing Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Biologics Outsourcing Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Outsourcing Services as of 2024)
Table 11. Global Biologics Outsourcing Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Biologics Outsourcing Services Companies Headquarters
Table 13. Global Biologics Outsourcing Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Biologics Outsourcing Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Biologics Outsourcing Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Biologics Outsourcing Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Biologics Outsourcing Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Biologics Outsourcing Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Biologics Outsourcing Services Growth Accelerators and Market Barriers
Table 25. North America Biologics Outsourcing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Biologics Outsourcing Services Growth Accelerators and Market Barriers
Table 27. Europe Biologics Outsourcing Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Biologics Outsourcing Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Biologics Outsourcing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Biologics Outsourcing Services Investment Opportunities and Key Challenges
Table 31. Central and South America Biologics Outsourcing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Biologics Outsourcing Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Biologics Outsourcing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Lonza Corporation Information
Table 35. Lonza Description and Major Businesses
Table 36. Lonza Product Features and Attributes
Table 37. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Lonza Revenue Proportion by Product in 2024
Table 39. Lonza Revenue Proportion by Application in 2024
Table 40. Lonza Revenue Proportion by Geographic Area in 2024
Table 41. Lonza Biologics Outsourcing Services SWOT Analysis
Table 42. Lonza Recent Developments
Table 43. Catalent Corporation Information
Table 44. Catalent Description and Major Businesses
Table 45. Catalent Product Features and Attributes
Table 46. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Catalent Revenue Proportion by Product in 2024
Table 48. Catalent Revenue Proportion by Application in 2024
Table 49. Catalent Revenue Proportion by Geographic Area in 2024
Table 50. Catalent Biologics Outsourcing Services SWOT Analysis
Table 51. Catalent Recent Developments
Table 52. Samsung Biologics Corporation Information
Table 53. Samsung Biologics Description and Major Businesses
Table 54. Samsung Biologics Product Features and Attributes
Table 55. Samsung Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Samsung Biologics Revenue Proportion by Product in 2024
Table 57. Samsung Biologics Revenue Proportion by Application in 2024
Table 58. Samsung Biologics Revenue Proportion by Geographic Area in 2024
Table 59. Samsung Biologics Biologics Outsourcing Services SWOT Analysis
Table 60. Samsung Biologics Recent Developments
Table 61. FUJIFILM Diosynth Biotechnologies Corporation Information
Table 62. FUJIFILM Diosynth Biotechnologies Description and Major Businesses
Table 63. FUJIFILM Diosynth Biotechnologies Product Features and Attributes
Table 64. FUJIFILM Diosynth Biotechnologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. FUJIFILM Diosynth Biotechnologies Revenue Proportion by Product in 2024
Table 66. FUJIFILM Diosynth Biotechnologies Revenue Proportion by Application in 2024
Table 67. FUJIFILM Diosynth Biotechnologies Revenue Proportion by Geographic Area in 2024
Table 68. FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services SWOT Analysis
Table 69. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Major Businesses
Table 72. Boehringer Ingelheim Product Features and Attributes
Table 73. Boehringer Ingelheim Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Boehringer Ingelheim Revenue Proportion by Product in 2024
Table 75. Boehringer Ingelheim Revenue Proportion by Application in 2024
Table 76. Boehringer Ingelheim Revenue Proportion by Geographic Area in 2024
Table 77. Boehringer Ingelheim Biologics Outsourcing Services SWOT Analysis
Table 78. Boehringer Ingelheim Recent Developments
Table 79. WuXi AppTech Corporation Information
Table 80. WuXi AppTech Description and Major Businesses
Table 81. WuXi AppTech Product Features and Attributes
Table 82. WuXi AppTech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. WuXi AppTech Recent Developments
Table 84. Recipharm Corporation Information
Table 85. Recipharm Description and Major Businesses
Table 86. Recipharm Product Features and Attributes
Table 87. Recipharm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Recipharm Recent Developments
Table 89. Thermo Fisher Scientific Corporation Information
Table 90. Thermo Fisher Scientific Description and Major Businesses
Table 91. Thermo Fisher Scientific Product Features and Attributes
Table 92. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Thermo Fisher Scientific Recent Developments
Table 94. AGC Biologics Corporation Information
Table 95. AGC Biologics Description and Major Businesses
Table 96. AGC Biologics Product Features and Attributes
Table 97. AGC Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. AGC Biologics Recent Developments
Table 99. Rentschler Biopharma Corporation Information
Table 100. Rentschler Biopharma Description and Major Businesses
Table 101. Rentschler Biopharma Product Features and Attributes
Table 102. Rentschler Biopharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Rentschler Biopharma Recent Developments
Table 104. KBI Biopharma Corporation Information
Table 105. KBI Biopharma Description and Major Businesses
Table 106. KBI Biopharma Product Features and Attributes
Table 107. KBI Biopharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. KBI Biopharma Recent Developments
Table 109. Siegfried Corporation Information
Table 110. Siegfried Description and Major Businesses
Table 111. Siegfried Product Features and Attributes
Table 112. Siegfried Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Siegfried Recent Developments
Table 114. Aenova Group Corporation Information
Table 115. Aenova Group Description and Major Businesses
Table 116. Aenova Group Product Features and Attributes
Table 117. Aenova Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Aenova Group Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Outsourcing Services Product Picture
Figure 2. Global Biologics Outsourcing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cell and Gene Therapies Product Picture
Figure 4. Antibodies Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biologics Outsourcing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. SMBs
Figure 9. Large Companies
Figure 10. Biologics Outsourcing Services Report Years Considered
Figure 11. Global Biologics Outsourcing Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 13. Global Biologics Outsourcing Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Biologics Outsourcing Services Revenue Market Share by Region (2020-2031)
Figure 15. Global Biologics Outsourcing Services Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Cell and Gene Therapies Revenue Market Share by Player in 2024
Figure 18. Antibodies Revenue Market Share by Player in 2024
Figure 19. Vaccines Revenue Market Share by Player in 2024
Figure 20. Other Revenue Market Share by Player in 2024
Figure 21. Global Biologics Outsourcing Services Revenue Market Share by Type (2020-2031)
Figure 22. Global Biologics Outsourcing Services Revenue Market Share by Application (2020-2031)
Figure 23. North America Biologics Outsourcing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Biologics Outsourcing Services Revenue (US$ Million) in 2024
Figure 25. North America Biologics Outsourcing Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Biologics Outsourcing Services Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Biologics Outsourcing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Biologics Outsourcing Services Revenue (US$ Million) in 2024
Figure 32. Europe Biologics Outsourcing Services Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Biologics Outsourcing Services Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 35. France Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Biologics Outsourcing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Biologics Outsourcing Services Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Biologics Outsourcing Services Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Biologics Outsourcing Services Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 47. India Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Biologics Outsourcing Services Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Biologics Outsourcing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Biologics Outsourcing Services Revenue (US$ Million) in 2024
Figure 55. Central and South America Biologics Outsourcing Services Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Biologics Outsourcing Services Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Biologics Outsourcing Services Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Biologics Outsourcing Services Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Biologics Outsourcing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Biologics Outsourcing Services Revenue (US$ Million) in 2024
Figure 61. South America Biologics Outsourcing Services Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Biologics Outsourcing Services Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Biologics Outsourcing Services Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Biologics Outsourcing Services Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Biologics Outsourcing Services Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Biologics Outsourcing Services Revenue (2020-2025) & (US$ Million)
Figure 67. Biologics Outsourcing Services Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
